Canaccord raised the firm’s price target on Illumina (ILMN) to $105 from $99 and keeps a Hold rating on the shares. The firm noted they reported 2Q25 results that were ahead of firm estimates and FactSet consensus. The target increase is driven by increased revenue in 2025 and beyond as well as modestly higher operating margin expansion.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target raised to $90 from $85 at Barclays
- Illumina’s Strategic Concerns and Uncertain Outlook: Sell Rating Reiterated with Lowered Price Objective
- Illumina’s Q2 2025 Earnings and Strategic Moves
- Hold Rating on Illumina Amid Strong Performance and Market Challenges
- Closing Bell Movers: Apple up 2%, Amazon down over 6% after results